Systematic review and meta-analysis of randomized clinical trials comparing efficacy and safety outcomes of insulin glargine with NPH insulin, premixed insulin preparations or with insulin detemir in type 2 diabetes mellitus

2015100 citationsReviewhybrid Open Access

Authors

P Rys · CRE Consulting (Poland)

Piotr Wojciechowski · CRE Consulting (Poland)

Agnieszka Rogoz-Sitek · CRE Consulting (Poland)

G Niesyczynski · CRE Consulting (Poland)

Joanna Lis · Institute of Philosophy and Sociology

Albert Syta · Institute of Philosophy and Sociology

Maciej T. Małecki

Abstract

For the majority of examined efficacy and safety outcomes, IGlar use in T2DM patients was superior or non-inferior to the alternative insulin treatment options.

Topics & Keywords

Diabetes Treatment and Management Diabetes Management and Research Diabetes and associated disorders

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Acta Diabetologica

Volume 52, Issue 4, pp. 649-662

DOI: 10.1007/s00592-014-0698-4

Field-Weighted Citation Impact: 8.27